Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p185
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 185/312)
Character Range: 16621386–16629797

P15546         CN15546          Fluticasone furoate with vilanterol                                    Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 15546
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have previously had frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids.
                                                                                                                           Patient must be aged 12 years or over.
C15548              P15548         CN15548          Budesonide with formoterol                                             Chronic obstructive pulmonary disease (COPD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 15548
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Fluticasone furoate with vilanterol                                    Patient must have significant symptoms despite regular beta-2 agonist bronchodilator therapy; AND
                                                                                                                           Patient must have experienced at least one severe COPD exacerbation, which required hospitalisation, or two or more moderate exacerbations in the previous 12 months.
                                                    Fluticasone propionate with salmeterol

C15550              P15550         CN15550          Escitalopram                                                           Moderate to severe generalised anxiety disorder (GAD)
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND
                                                                                                                           Patient must not have responded to non-pharmacological therapy; AND
                                                                                                                           Patient must have been assessed by a psychiatrist.
C15551              P15551         CN15551          Escitalopram                                                           Moderate to severe social anxiety disorder (social phobia, SAD)
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           The condition must be defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria; AND
                                                                                                                           Patient must not have responded to non-pharmacological therapy; AND
                                                                                                                           Patient must be one for whom a GP Mental Health Care Plan, as described under items 2715 or 2717 of the Medicare Benefits Schedule, has been prepared.
C15553              P15553         CN15553          Desvenlafaxine                                                         Major depressive disorders
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
                                                    Mirtazapine

                                                    Moclobemide

                                                    Reboxetine

                                                    Venlafaxine

C15556              P15556         CN15556          Carbomer                                                               Severe dry eye syndrome
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
                                                    Hypromellose

                                                    Hypromellose with dextran

                                                    Polyethylene glycol 400 with propylene glycol

C15558              P15558         CN15558          Bimatoprost with timolol                                               Elevated intra-ocular pressure
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Brimonidine with timolol                                               The condition must have been inadequately controlled with monotherapy; AND
                                                                                                                           Patient must have open-angle glaucoma; OR
                                                    Brinzolamide with brimonidine                                          Patient must have ocular hypertension.

                                                    Brinzolamide with timolol

                                                    Dorzolamide with timolol

                                                    Latanoprost with timolol